All News

Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).

The MMR vaccine may demonstrate some degree of protection against septic inflammation, a symptom of COVID-19, according to a team of experts.

Results of a PLOS ONE study determined a positive relationship between COPD and smoking and mortality rates from COVID-19.

A new poll by Gallup and West Health found that a majority of Americans have expressed numerous health care system-related concerns, including rising costs of drugs, insurance premiums, and health care in response to COVID-19.

The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.

Until social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.

Here's a roundup of this week's coronavirus-related news.

As reopening efforts and recovery plans start to take hold, it should be recognized that community pharmacies are ideally positioned to support this national effort.

EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.

Via a new web platform, pharmacy technicians are sharing their personal challenges during the coronavirus disease 2019 (COVID-19) pandemic.

The FDA updated its fact sheet on the co-administration of remdesivir with chloroquine phosphate or hydroxychloroquine.

Abbott’s FreeStyle Libre 2 is an integrated continuous glucose monitoring system for adults and children ages 4 and older with diabetes.

Armand Balboni, MD, PhD, chief executive officer of Appili Therapeutics, discusses the potential for favipiravir, an antiviral medication, for treating COVID-19 in certain populations.

Since the emergency use authorization was granted, new data on heart risks associated with hydroxychloroquine and chloroquine have been revealed.

Officials with the FDA have approved dolutegravir (Tivicay PD, ViiV Healthcare) dispersible tablets for oral suspension for children who are at least 4 weeks of age and weigh at least 3 kg.

In part 2 of our interview, Armand Balboni, MD, PhD, chief executive officer of Appili Therapeutics, discusses the potential for favipiravir, an antiviral medication, for treating COVID-19 in certain populations.

An analysis focused on patients with type 2 diabetes in rural regions, where accessibility to physicians is often limited.

Here's a roundup of the latest coronavirus-related news. 

Survey respondents contradicted prior research that has suggested that manufacturer changes in medication appearance affect perceptions of safety and effectiveness.

This small, 1200-square-foot drugstore will take care of the patients and their problems that the big-box guys could care less about.

The National Association of Boards of Pharmacy (NABP) has issued nearly 50,000 “passports,” or temporary licenses, for pharmacists and pharmacy technicians.

In evaluating data according to the chronic conditions present in the study, those with COPD or depression demonstrated higher reports of social determinants of health than other demographics did.

An exploratory analysis of 2 phase 3 trials evaluating ribociclib (Kisqali, Novartis) plus endocrine therapy in advanced breast cancer showed positive results.

Syndromic surveillance apps may be key in providing solutions to limitations on current COVID-19 case projection data collection efforts.

Oncology pharmacy practitioners highlight challenges amid the pandemic, such as limited access to personal protective equipment and essential medications.

Though antibiotics are crucial, concern about overuse in hospitals and inappropriate prescribing practices fuels debate about the complex relationship between antibiotic use and antimicrobial resistance.

“Err on the side of caution. One large data breach could [affect all] your patients, your employees, and yourself.”

Armand Balboni, MD, PhD, chief executive officer of Appili Therapeutics, discusses the potential for favipiravir, an antiviral medication, for treating COVID-19 in certain populations.